Remote Access to Care, Everywhere, for Parkinson Disease

Study Overview
=================
Brief Summary
-----------------
The primary objective of this study is to evaluate the feasibility, efficacy and the value of providing care to individuals with Parkinson disease directly into their homes. The specific aims are: To demonstrate the feasibility of conducting remote evaluations of patients with Parkinson disease nationally; To measure the impact of remote care on each patient's ability to improve his or her quality of life (QoL) and better manage his or her Parkinson disease; and To assess the long-term acceptability to patients in receiving ongoing care remotely via telemedicine.

Official Title
-----------------
Remote Access to Care, Everywhere: Using Telemedicine to Deliver Patient-centered Care to Patients With Parkinson Disease

Conditions
-----------------
Parkinson Disease

Intervention / Treatment
-----------------
* Other: Virtual care visit


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Age greater than 30 Self reported diagnosis of idiopathic Parkinson disease Ability to converse in English Ability and willingness to provide informed consent and complete study requirements Access to a non-public computer or similar devices with broadband internet. Located in New York, Maryland, Delaware, California, or Florida at time of virtual visit (or veterans with Parkinson disease anywhere in the U.S.) Exclusion Criteria: Any condition (e.g.prominent psychosis) that in the investigator's or coordinator's judgment would preclude participation. Concurrent enrollment in another telemedicine study.

Ages Eligible for Study
-----------------
Minimum Age: 30 Years
Maximum Age: 120 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Health Services Research
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Virtual care visit<br>One-time virtual care visit for Parkinson disease. | Other: Virtual care visit<br>* Video-conferencing visit with a Parkinson disease specialist<br>* Other names: Virtual house call;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Feasibility | The percent of telemedicine visits completed as scheduled. (Goal >80%) | 6 months | 
| Change in Quality of Life as Measured by the PDQ-39 Assessment Tool | The impact on Quality of life (QoL) as measured by the change in PDQ-39 score from baseline to 6 months. The PDQ-39 is a 39-item self-report questionnaire, which assesses Parkinson's disease-specific health related quality over the last month. 5-point ordinal scoring system: 0 = never, 1 = occasionally, 2 = sometimes, 3 = often, 4 = always. Each dimension total score range from 0 (never have difficulty) to 100 (always have difficulty). Lower scores reflect better quality of life. | Baseline and 6 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Acceptability | - The percent of patients participated who stated that they are interested in receiving ongoing care for their PD via telemedicine. (Goal >80%) | 6 months | 
| Feasibility (Descriptive) | Percentage of physician visits where the physician was were satisfied or very satisfied with the virtual visit overall. | 6 months | 
| Percentage of Patients Who Felt That the Recommendations Improved Their Health |  | 6 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Telemedicine, Virtual care visit, Remote visit, Video-conferencing